This text presents a broad-based review of the contemporary field of drugs for schizophrenia and is intended for graduate and postgraduate students and mental health professionals. It consists of 34 chapters by well-known experts in the field addressing basic mechanisms in the pathophysiology of schizophrenia, neuropharmacology, experimental strategies, atypical antipsychotics, and other clinical issues
